Overview

Suprachoroidal Injection of CLS-TA in Subjects With Macular Edema Associated With Non-infectious Uveitis

Status:
Completed
Trial end date:
2018-01-18
Target enrollment:
Participant gender:
Summary
The study is designed to evaluate the safety and efficacy of suprachoroidally administered triamcinolone acetonide, CLS-TA, in subjects with macular edema associated with non-infectious uveitis.
Phase:
Phase 3
Details
Lead Sponsor:
Clearside Biomedical, Inc.
Treatments:
Triamcinolone
Triamcinolone Acetonide
Triamcinolone diacetate
Triamcinolone hexacetonide